Found 20 matching trials
Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment PHASE3 This randomized phase III trial studies testosterone to see how well it wor...
Show More Location
Anchorage Associates in Radiation Medicine
Learn More & Join Trial
Efficacy and Safety of Oxybutynin Versus Paroxetine in Aromatase Inhibitor-induced Vasomotor Symptoms PHASE3 Breast cancer is the most prevalent cancer type worldwide. In Egypt, It is ...
Show More Location
Dar El-Salam Cancer Hospital
Learn More & Join Trial
The Cardiovascular Impact of Hot Flushes N/A The overall objective of this study is to examine the physiological respons...
Show More Location
University of Minnesota
Learn More & Join Trial
Acupuncture Versus Sham Acupuncture or Usual Care for Antiandrogen-Induced Hot fLashes in Prostate Cancer (AVAIL) NA Hot flashes are a common and debilitating symptom among prostate cancer pat...
Show More Location
Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & Nanjing Medical University Affiliated Cancer Hospital
Learn More & Join Trial
Understanding Experimentally Induced Hot Flushes PHASE4 The purpose of the study is to examine the impact of hot flushes on sleep, ...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Acupuncture Treatment of Vasomotor Symptoms in Breast Cancer Patients NA The goal of this clinical trial is to evaluate the impact of acupuncture in...
Show More Location
Fondazione Policlinico Gemelli- IRCCS
Learn More & Join Trial
Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients PHASE2 At present, the treatment of recurrent ovarian cancer after PARP inhibitor ...
Show More Location
Fudan university shanghai cancer center, Deparment of gynecologic oncology
Learn More & Join Trial
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer PHASE3 Researchers are looking for a better way to treat women with, or at high ri...
Show More Status
Active Not Recruiting
Location
AKH Wien | Allg. Gynaekologie & gynaekologische Onkologie
Learn More & Join Trial
Psychosexual Consequences of Risk-reducing Salpingo-oophorectomy NA Short Rationale: Risk-reducing salpingo-oophorectomy (RRSO) is a mainstay i...
Show More Location
University Medical Centre Groningen
Learn More & Join Trial
Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer PHASE2 Due to the fact that majority of breast cancers are estrogen-receptor and/o...
Show More Location
Changhua Christain Hospital
Learn More & Join Trial